While gene editing offers the exciting potential for disease therapies, using it on human embryos opens up a can of worms.
Rigor acadêmico, estilo jornalístico
Todos os artigos de Gene editing
Exibindo 101 - 103 de 103 artigos
Despite predictions, the CRISPR/Cas9 gene editing technique didn’t win the Nobel Prize. But with the technology nevertheless taking off, it is time we start having an informed public debate about it.
Until more is understood, it’s sensible to limit experimentation that would make changes to germ line cells that would be passed on to future generations.
Principais colaboradores
-
Deputy Vice-Chancellor Academic Quality and Professor of Molecular Biology, UNSW Sydney
-
Assistant Professor in Biomedical Ethics, National University of Singapore
-
Geneticist and Group Leader, The John Curtin School of Medical Research, Australian National University
-
Associate professor, Queensland University of Technology
-
Professor of Chemistry, Connecticut College
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Shah Rising Star Assistant Professor of Chemical Engineering, Herbert Wertheim College of Engineering, UF Health Cancer Center, University of Florida
-
Vanier Scholar and Ph.D. Candidate in Microbiology and Immunology, Dalhousie University
-
Researcher, Lecturer, Attorney, University of KwaZulu-Natal
-
Visiting Professor in Biomedical Ethics, Murdoch Children's Research Institute; Distinguished Visiting Professor in Law, University of Melbourne; Uehiro Chair in Practical Ethics, University of Oxford
-
Doctoral Student in Biochemistry, University of Washington
-
Director of Research and Professor of Pathology, Dalhousie University
-
Professor of Advanced Technology Transitions, Arizona State University
-
Research fellow, The University of Queensland
-
Senior Lecturer, School of BioSciences, The University of Melbourne
